Robert M. Wenham

MicroRNA Expression Profiling in Human Ovarian Cancer: <i>miR-214</i> Induces Cell Survival and Cisplatin Resistance by Targeting <i>PTEN</i>

Hua Yang, William Kong, Lili He et al. · Cancer Research · 2008 · 1K citations · Full text

Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer

Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson et al. · Journal of Clinical Oncology · 2007 · 754 citations

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Shahneen Sandhu, William R. Schelman, George Wilding et al. · The Lancet Oncology · 2013 · 551 citations

Sporadic Cancer, Medicine, Brca Mutation Carriers +7

Monsel's Solution: A Brief History

Audrey P. Garrett, Robert M. Wenham, Ellen E. Sheets · Journal of Lower Genital Tract Disease · 2002 · 379 citations

Audrey P. Md, Patient Safety, Clinical Evidence +6

IgA transcytosis and antigen recognition govern ovarian cancer immunity

Subir Biswas, Gunjan Mandal, Kyle K. Payne et al. · Nature · 2021 · 225 citations · Full text